In the intricate puzzle of multiple sclerosis (MS) diagnosis, the combination of cortical lesions (CLs) and the central vein sign (CVS) on magnetic resonance imaging (MRI) emerges as a significant ...

May 13, 2004 — Simvastatin at a dose of 80 mg is associated with reduced number and volume of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) at six months, according to the ...

Chronic active lesions are not only common in patients with multiple sclerosis (MS) but are also associated with more aggressive and disabling forms of the disease, according to researchers from ...

Multiple Sclerosis: New MRI Contrast Medium Enables Early Diagnosis In Animal Model. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2008 / 08 / 080801152139.htm ...

A retrospective, five-year study of 1,314 patients with multiple sclerosis (MS) has found that atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which ...

Chronic active lesions -- dark-rimmed spots indicating ongoing, smoldering inflammation on 3T or 7T MRI susceptibility sequences -- were common in multiple sclerosis (MS) and tied to disability ...

In children with multiple sclerosis, teriflunomide tempers lesion growth. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2021 / 11 / 211130174008.htm ...

WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of ...

NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested.

In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Würzburg have been able to visualize inflammatory tissue damage ...